Corcept Therapeutics CORT
NASDAQ CORT
$75.03 +2.26 (+3.11%)
At close: Nov 9, 2026 · 4:00 PM EST

Corcept Therapeutics (CORT) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Corcept Therapeutics (CORT) posted Return on Capital Employed [ROCE] of 14.15% for Q3 2026, up 3.91 percentage points from 10.24% a year earlier and up 13.23 percentage points from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Corcept Therapeutics' Return on Capital Employed [ROCE] came in at 6.66%, down 16.54 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of -22.18 percentage points (FY2020 to FY2025).
  • In prior years, Corcept Therapeutics' Return on Capital Employed [ROCE] was 23.20% in FY2024 (+1.66 pp), 21.54% in FY2023 (-4.58 pp), 26.13% in FY2022 (-1.52 pp) and 27.65% in FY2021 (-1.19 pp).
  • The Q3 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q2 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in 1 of the last eight quarters, with an average year-over-year change of -8.52 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2022, with a gain of 12.74 percentage points; the weakest was Q1 2026, with a drop of 17.04 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 0.92% (Q2 2026), -1.21% (Q1 2026) and 6.75% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.52%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 21.60%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 5.33%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 9.91%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 17.37%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -6.15%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 11.32%
10 Corcept Therapeutics 7.99 Bn 6.60 Bn 335.86 Mn 14.15%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.15%
Jun 30, 2026 0.92%
Mar 31, 2026 -1.21%
Dec 31, 2025 6.75%
Sep 30, 2025 10.24%
Jun 30, 2025 15.01%
Mar 31, 2025 15.83%
Dec 31, 2024 20.39%
Sep 30, 2024 23.00%
Jun 30, 2024 21.89%
Mar 31, 2024 22.52%
Dec 31, 2023 21.32%
Sep 30, 2023 22.43%
Jun 30, 2023 20.68%
Mar 31, 2023 19.30%
Dec 31, 2022 23.18%
Sep 30, 2022 27.46%
Jun 30, 2022 30.26%
Mar 31, 2022 33.86%
Dec 31, 2021 27.24%
API Access

Corcept Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CORT&period=max&api_key=YOUR_API_KEY